nodes	percent_of_prediction	percent_of_DWPC	metapath
Mexiletine—CYP2B6—Ifosfamide—testicular cancer	0.16	0.27	CbGbCtD
Mexiletine—CYP2B6—Cisplatin—testicular cancer	0.0778	0.131	CbGbCtD
Mexiletine—CYP2E1—Etoposide—testicular cancer	0.0775	0.131	CbGbCtD
Mexiletine—CYP2B6—Doxorubicin—testicular cancer	0.0522	0.0879	CbGbCtD
Mexiletine—CYP3A4—Ifosfamide—testicular cancer	0.0492	0.0828	CbGbCtD
Mexiletine—CYP1A2—Etoposide—testicular cancer	0.0448	0.0756	CbGbCtD
Mexiletine—CYP2D6—Vinblastine—testicular cancer	0.041	0.0691	CbGbCtD
Mexiletine—CYP3A4—Vinblastine—testicular cancer	0.0261	0.0439	CbGbCtD
Mexiletine—CYP2D6—Doxorubicin—testicular cancer	0.0252	0.0425	CbGbCtD
Mexiletine—CYP3A4—Etoposide—testicular cancer	0.0235	0.0396	CbGbCtD
Mexiletine—CYP3A4—Doxorubicin—testicular cancer	0.016	0.027	CbGbCtD
Mexiletine—Headache—Vinblastine—testicular cancer	0.000676	0.00166	CcSEcCtD
Mexiletine—Leukopenia—Etoposide—testicular cancer	0.000675	0.00166	CcSEcCtD
Mexiletine—Abdominal pain—Dactinomycin—testicular cancer	0.000672	0.00165	CcSEcCtD
Mexiletine—Body temperature increased—Dactinomycin—testicular cancer	0.000672	0.00165	CcSEcCtD
Mexiletine—Fatigue—Ifosfamide—testicular cancer	0.000672	0.00165	CcSEcCtD
Mexiletine—Oedema—Cisplatin—testicular cancer	0.000672	0.00165	CcSEcCtD
Mexiletine—Hypersensitivity—Bleomycin—testicular cancer	0.000672	0.00165	CcSEcCtD
Mexiletine—Pain—Ifosfamide—testicular cancer	0.000667	0.00164	CcSEcCtD
Mexiletine—Constipation—Ifosfamide—testicular cancer	0.000667	0.00164	CcSEcCtD
Mexiletine—Loss of consciousness—Etoposide—testicular cancer	0.000663	0.00163	CcSEcCtD
Mexiletine—Ataxia—Epirubicin—testicular cancer	0.00066	0.00162	CcSEcCtD
Mexiletine—Thrombocytopenia—Cisplatin—testicular cancer	0.000658	0.00162	CcSEcCtD
Mexiletine—Asthenia—Bleomycin—testicular cancer	0.000654	0.00161	CcSEcCtD
Mexiletine—Convulsion—Etoposide—testicular cancer	0.000654	0.00161	CcSEcCtD
Mexiletine—Hypertension—Etoposide—testicular cancer	0.000651	0.0016	CcSEcCtD
Mexiletine—Hyperhidrosis—Cisplatin—testicular cancer	0.00065	0.0016	CcSEcCtD
Mexiletine—Liver function test abnormal—Epirubicin—testicular cancer	0.000648	0.00159	CcSEcCtD
Mexiletine—Dry skin—Epirubicin—testicular cancer	0.000644	0.00158	CcSEcCtD
Mexiletine—Feeling abnormal—Ifosfamide—testicular cancer	0.000642	0.00158	CcSEcCtD
Mexiletine—Chest pain—Etoposide—testicular cancer	0.000642	0.00158	CcSEcCtD
Mexiletine—Nausea—Vinblastine—testicular cancer	0.000641	0.00158	CcSEcCtD
Mexiletine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000637	0.00157	CcSEcCtD
Mexiletine—Pancreatitis—Methotrexate—testicular cancer	0.000636	0.00156	CcSEcCtD
Mexiletine—Discomfort—Etoposide—testicular cancer	0.000634	0.00156	CcSEcCtD
Mexiletine—Hypotension—Cisplatin—testicular cancer	0.000628	0.00154	CcSEcCtD
Mexiletine—Hypersensitivity—Dactinomycin—testicular cancer	0.000627	0.00154	CcSEcCtD
Mexiletine—Abdominal discomfort—Methotrexate—testicular cancer	0.000622	0.00153	CcSEcCtD
Mexiletine—Confusional state—Etoposide—testicular cancer	0.000621	0.00153	CcSEcCtD
Mexiletine—Abdominal pain—Ifosfamide—testicular cancer	0.000616	0.00152	CcSEcCtD
Mexiletine—Body temperature increased—Ifosfamide—testicular cancer	0.000616	0.00152	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000612	0.00151	CcSEcCtD
Mexiletine—Ataxia—Doxorubicin—testicular cancer	0.000611	0.0015	CcSEcCtD
Mexiletine—Asthenia—Dactinomycin—testicular cancer	0.00061	0.0015	CcSEcCtD
Mexiletine—Dysphagia—Epirubicin—testicular cancer	0.000607	0.00149	CcSEcCtD
Mexiletine—Neutropenia—Methotrexate—testicular cancer	0.000606	0.00149	CcSEcCtD
Mexiletine—Paraesthesia—Cisplatin—testicular cancer	0.000603	0.00148	CcSEcCtD
Mexiletine—Thrombocytopenia—Etoposide—testicular cancer	0.000603	0.00148	CcSEcCtD
Mexiletine—Liver function test abnormal—Doxorubicin—testicular cancer	0.0006	0.00148	CcSEcCtD
Mexiletine—Dyspnoea—Cisplatin—testicular cancer	0.000599	0.00147	CcSEcCtD
Mexiletine—Erectile dysfunction—Methotrexate—testicular cancer	0.000597	0.00147	CcSEcCtD
Mexiletine—Dry skin—Doxorubicin—testicular cancer	0.000595	0.00146	CcSEcCtD
Mexiletine—Hyperhidrosis—Etoposide—testicular cancer	0.000595	0.00146	CcSEcCtD
Mexiletine—Pancreatitis—Epirubicin—testicular cancer	0.000595	0.00146	CcSEcCtD
Mexiletine—Angina pectoris—Epirubicin—testicular cancer	0.000591	0.00145	CcSEcCtD
Mexiletine—Diarrhoea—Dactinomycin—testicular cancer	0.000582	0.00143	CcSEcCtD
Mexiletine—Vomiting—Bleomycin—testicular cancer	0.00058	0.00143	CcSEcCtD
Mexiletine—Drowsiness—Methotrexate—testicular cancer	0.000578	0.00142	CcSEcCtD
Mexiletine—Depression—Methotrexate—testicular cancer	0.000576	0.00142	CcSEcCtD
Mexiletine—Hypotension—Etoposide—testicular cancer	0.000575	0.00141	CcSEcCtD
Mexiletine—Rash—Bleomycin—testicular cancer	0.000575	0.00141	CcSEcCtD
Mexiletine—Pain—Cisplatin—testicular cancer	0.000575	0.00141	CcSEcCtD
Mexiletine—Dermatitis—Bleomycin—testicular cancer	0.000574	0.00141	CcSEcCtD
Mexiletine—Hypersensitivity—Ifosfamide—testicular cancer	0.000574	0.00141	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000573	0.00141	CcSEcCtD
Mexiletine—Neutropenia—Epirubicin—testicular cancer	0.000567	0.0014	CcSEcCtD
Mexiletine—Dysphagia—Doxorubicin—testicular cancer	0.000561	0.00138	CcSEcCtD
Mexiletine—Asthenia—Ifosfamide—testicular cancer	0.000559	0.00138	CcSEcCtD
Mexiletine—Feeling abnormal—Cisplatin—testicular cancer	0.000554	0.00136	CcSEcCtD
Mexiletine—Paraesthesia—Etoposide—testicular cancer	0.000553	0.00136	CcSEcCtD
Mexiletine—Pancreatitis—Doxorubicin—testicular cancer	0.00055	0.00135	CcSEcCtD
Mexiletine—Dyspnoea—Etoposide—testicular cancer	0.000549	0.00135	CcSEcCtD
Mexiletine—Somnolence—Etoposide—testicular cancer	0.000547	0.00135	CcSEcCtD
Mexiletine—Angina pectoris—Doxorubicin—testicular cancer	0.000547	0.00135	CcSEcCtD
Mexiletine—Nausea—Bleomycin—testicular cancer	0.000542	0.00133	CcSEcCtD
Mexiletine—Drowsiness—Epirubicin—testicular cancer	0.000541	0.00133	CcSEcCtD
Mexiletine—Vomiting—Dactinomycin—testicular cancer	0.000541	0.00133	CcSEcCtD
Mexiletine—Agranulocytosis—Methotrexate—testicular cancer	0.00054	0.00133	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000536	0.00132	CcSEcCtD
Mexiletine—Rash—Dactinomycin—testicular cancer	0.000536	0.00132	CcSEcCtD
Mexiletine—Diarrhoea—Ifosfamide—testicular cancer	0.000533	0.00131	CcSEcCtD
Mexiletine—Body temperature increased—Cisplatin—testicular cancer	0.000531	0.00131	CcSEcCtD
Mexiletine—Fatigue—Etoposide—testicular cancer	0.000531	0.00131	CcSEcCtD
Mexiletine—Pain—Etoposide—testicular cancer	0.000526	0.00129	CcSEcCtD
Mexiletine—Constipation—Etoposide—testicular cancer	0.000526	0.00129	CcSEcCtD
Mexiletine—Neutropenia—Doxorubicin—testicular cancer	0.000525	0.00129	CcSEcCtD
Mexiletine—Hepatitis—Methotrexate—testicular cancer	0.000519	0.00128	CcSEcCtD
Mexiletine—Dizziness—Ifosfamide—testicular cancer	0.000515	0.00127	CcSEcCtD
Mexiletine—Pharyngitis—Methotrexate—testicular cancer	0.000515	0.00127	CcSEcCtD
Mexiletine—Feeling abnormal—Etoposide—testicular cancer	0.000507	0.00125	CcSEcCtD
Mexiletine—Nausea—Dactinomycin—testicular cancer	0.000505	0.00124	CcSEcCtD
Mexiletine—Agranulocytosis—Epirubicin—testicular cancer	0.000505	0.00124	CcSEcCtD
Mexiletine—Gastrointestinal pain—Etoposide—testicular cancer	0.000503	0.00124	CcSEcCtD
Mexiletine—Drowsiness—Doxorubicin—testicular cancer	0.000501	0.00123	CcSEcCtD
Mexiletine—Visual impairment—Methotrexate—testicular cancer	0.0005	0.00123	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000496	0.00122	CcSEcCtD
Mexiletine—Vomiting—Ifosfamide—testicular cancer	0.000496	0.00122	CcSEcCtD
Mexiletine—Hypersensitivity—Cisplatin—testicular cancer	0.000495	0.00122	CcSEcCtD
Mexiletine—Bradycardia—Epirubicin—testicular cancer	0.000494	0.00122	CcSEcCtD
Mexiletine—Rash—Ifosfamide—testicular cancer	0.000491	0.00121	CcSEcCtD
Mexiletine—Dermatitis—Ifosfamide—testicular cancer	0.000491	0.00121	CcSEcCtD
Mexiletine—Erythema multiforme—Methotrexate—testicular cancer	0.000491	0.00121	CcSEcCtD
Mexiletine—Abdominal pain—Etoposide—testicular cancer	0.000487	0.0012	CcSEcCtD
Mexiletine—Body temperature increased—Etoposide—testicular cancer	0.000487	0.0012	CcSEcCtD
Mexiletine—Hepatitis—Epirubicin—testicular cancer	0.000486	0.00119	CcSEcCtD
Mexiletine—Tinnitus—Methotrexate—testicular cancer	0.000484	0.00119	CcSEcCtD
Mexiletine—Hypoaesthesia—Epirubicin—testicular cancer	0.000483	0.00119	CcSEcCtD
Mexiletine—Asthenia—Cisplatin—testicular cancer	0.000482	0.00119	CcSEcCtD
Mexiletine—Pharyngitis—Epirubicin—testicular cancer	0.000482	0.00119	CcSEcCtD
Mexiletine—Visual impairment—Epirubicin—testicular cancer	0.000468	0.00115	CcSEcCtD
Mexiletine—Agranulocytosis—Doxorubicin—testicular cancer	0.000467	0.00115	CcSEcCtD
Mexiletine—Nausea—Ifosfamide—testicular cancer	0.000463	0.00114	CcSEcCtD
Mexiletine—Diarrhoea—Cisplatin—testicular cancer	0.00046	0.00113	CcSEcCtD
Mexiletine—Erythema multiforme—Epirubicin—testicular cancer	0.000459	0.00113	CcSEcCtD
Mexiletine—Alopecia—Methotrexate—testicular cancer	0.000459	0.00113	CcSEcCtD
Mexiletine—Bradycardia—Doxorubicin—testicular cancer	0.000458	0.00113	CcSEcCtD
Mexiletine—Hypersensitivity—Etoposide—testicular cancer	0.000454	0.00112	CcSEcCtD
Mexiletine—Tinnitus—Epirubicin—testicular cancer	0.000453	0.00111	CcSEcCtD
Mexiletine—Hepatitis—Doxorubicin—testicular cancer	0.000449	0.00111	CcSEcCtD
Mexiletine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000447	0.0011	CcSEcCtD
Mexiletine—Pharyngitis—Doxorubicin—testicular cancer	0.000446	0.0011	CcSEcCtD
Mexiletine—Dysgeusia—Methotrexate—testicular cancer	0.000442	0.00109	CcSEcCtD
Mexiletine—Asthenia—Etoposide—testicular cancer	0.000442	0.00109	CcSEcCtD
Mexiletine—Arrhythmia—Epirubicin—testicular cancer	0.000434	0.00107	CcSEcCtD
Mexiletine—Visual impairment—Doxorubicin—testicular cancer	0.000433	0.00107	CcSEcCtD
Mexiletine—Alopecia—Epirubicin—testicular cancer	0.000429	0.00106	CcSEcCtD
Mexiletine—Vomiting—Cisplatin—testicular cancer	0.000427	0.00105	CcSEcCtD
Mexiletine—Vision blurred—Methotrexate—testicular cancer	0.000426	0.00105	CcSEcCtD
Mexiletine—Erythema multiforme—Doxorubicin—testicular cancer	0.000425	0.00105	CcSEcCtD
Mexiletine—Rash—Cisplatin—testicular cancer	0.000424	0.00104	CcSEcCtD
Mexiletine—Dermatitis—Cisplatin—testicular cancer	0.000423	0.00104	CcSEcCtD
Mexiletine—Diarrhoea—Etoposide—testicular cancer	0.000421	0.00104	CcSEcCtD
Mexiletine—Ill-defined disorder—Methotrexate—testicular cancer	0.000419	0.00103	CcSEcCtD
Mexiletine—Tinnitus—Doxorubicin—testicular cancer	0.000419	0.00103	CcSEcCtD
Mexiletine—Tension—Epirubicin—testicular cancer	0.000415	0.00102	CcSEcCtD
Mexiletine—Dysgeusia—Epirubicin—testicular cancer	0.000414	0.00102	CcSEcCtD
Mexiletine—Nervousness—Epirubicin—testicular cancer	0.000411	0.00101	CcSEcCtD
Mexiletine—Malaise—Methotrexate—testicular cancer	0.000407	0.001	CcSEcCtD
Mexiletine—Dizziness—Etoposide—testicular cancer	0.000407	0.001	CcSEcCtD
Mexiletine—Muscle spasms—Epirubicin—testicular cancer	0.000406	0.001	CcSEcCtD
Mexiletine—Leukopenia—Methotrexate—testicular cancer	0.000404	0.000995	CcSEcCtD
Mexiletine—Arrhythmia—Doxorubicin—testicular cancer	0.000401	0.000987	CcSEcCtD
Mexiletine—Nausea—Cisplatin—testicular cancer	0.000399	0.000982	CcSEcCtD
Mexiletine—Vision blurred—Epirubicin—testicular cancer	0.000398	0.00098	CcSEcCtD
Mexiletine—Alopecia—Doxorubicin—testicular cancer	0.000397	0.000977	CcSEcCtD
Mexiletine—Ill-defined disorder—Epirubicin—testicular cancer	0.000392	0.000965	CcSEcCtD
Mexiletine—Convulsion—Methotrexate—testicular cancer	0.000391	0.000963	CcSEcCtD
Mexiletine—Vomiting—Etoposide—testicular cancer	0.000391	0.000963	CcSEcCtD
Mexiletine—Rash—Etoposide—testicular cancer	0.000388	0.000955	CcSEcCtD
Mexiletine—Dermatitis—Etoposide—testicular cancer	0.000388	0.000954	CcSEcCtD
Mexiletine—Headache—Etoposide—testicular cancer	0.000386	0.000948	CcSEcCtD
Mexiletine—Arthralgia—Methotrexate—testicular cancer	0.000385	0.000946	CcSEcCtD
Mexiletine—Chest pain—Methotrexate—testicular cancer	0.000385	0.000946	CcSEcCtD
Mexiletine—Tension—Doxorubicin—testicular cancer	0.000384	0.000944	CcSEcCtD
Mexiletine—Dysgeusia—Doxorubicin—testicular cancer	0.000383	0.000942	CcSEcCtD
Mexiletine—Malaise—Epirubicin—testicular cancer	0.000381	0.000938	CcSEcCtD
Mexiletine—Discomfort—Methotrexate—testicular cancer	0.00038	0.000935	CcSEcCtD
Mexiletine—Nervousness—Doxorubicin—testicular cancer	0.00038	0.000935	CcSEcCtD
Mexiletine—Syncope—Epirubicin—testicular cancer	0.000379	0.000933	CcSEcCtD
Mexiletine—Leukopenia—Epirubicin—testicular cancer	0.000378	0.000931	CcSEcCtD
Mexiletine—Muscle spasms—Doxorubicin—testicular cancer	0.000376	0.000925	CcSEcCtD
Mexiletine—Palpitations—Epirubicin—testicular cancer	0.000374	0.000919	CcSEcCtD
Mexiletine—Confusional state—Methotrexate—testicular cancer	0.000372	0.000914	CcSEcCtD
Mexiletine—Loss of consciousness—Epirubicin—testicular cancer	0.000372	0.000914	CcSEcCtD
Mexiletine—Vision blurred—Doxorubicin—testicular cancer	0.000369	0.000907	CcSEcCtD
Mexiletine—Convulsion—Epirubicin—testicular cancer	0.000366	0.000901	CcSEcCtD
Mexiletine—Nausea—Etoposide—testicular cancer	0.000366	0.000899	CcSEcCtD
Mexiletine—Hypertension—Epirubicin—testicular cancer	0.000365	0.000898	CcSEcCtD
Mexiletine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000363	0.000893	CcSEcCtD
Mexiletine—Thrombocytopenia—Methotrexate—testicular cancer	0.000361	0.000888	CcSEcCtD
Mexiletine—Arthralgia—Epirubicin—testicular cancer	0.00036	0.000885	CcSEcCtD
Mexiletine—Chest pain—Epirubicin—testicular cancer	0.00036	0.000885	CcSEcCtD
Mexiletine—Hyperhidrosis—Methotrexate—testicular cancer	0.000356	0.000877	CcSEcCtD
Mexiletine—Discomfort—Epirubicin—testicular cancer	0.000356	0.000875	CcSEcCtD
Mexiletine—Malaise—Doxorubicin—testicular cancer	0.000353	0.000868	CcSEcCtD
Mexiletine—Dry mouth—Epirubicin—testicular cancer	0.000352	0.000866	CcSEcCtD
Mexiletine—Syncope—Doxorubicin—testicular cancer	0.000351	0.000863	CcSEcCtD
Mexiletine—Leukopenia—Doxorubicin—testicular cancer	0.00035	0.000861	CcSEcCtD
Mexiletine—Confusional state—Epirubicin—testicular cancer	0.000348	0.000856	CcSEcCtD
Mexiletine—Palpitations—Doxorubicin—testicular cancer	0.000346	0.00085	CcSEcCtD
Mexiletine—Oedema—Epirubicin—testicular cancer	0.000345	0.000849	CcSEcCtD
Mexiletine—Hypotension—Methotrexate—testicular cancer	0.000345	0.000847	CcSEcCtD
Mexiletine—Loss of consciousness—Doxorubicin—testicular cancer	0.000344	0.000846	CcSEcCtD
Mexiletine—Shock—Epirubicin—testicular cancer	0.000339	0.000835	CcSEcCtD
Mexiletine—Convulsion—Doxorubicin—testicular cancer	0.000339	0.000834	CcSEcCtD
Mexiletine—Thrombocytopenia—Epirubicin—testicular cancer	0.000338	0.000831	CcSEcCtD
Mexiletine—Hypertension—Doxorubicin—testicular cancer	0.000338	0.000831	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000336	0.000826	CcSEcCtD
Mexiletine—Hyperhidrosis—Epirubicin—testicular cancer	0.000334	0.00082	CcSEcCtD
Mexiletine—Arthralgia—Doxorubicin—testicular cancer	0.000333	0.000819	CcSEcCtD
Mexiletine—Chest pain—Doxorubicin—testicular cancer	0.000333	0.000819	CcSEcCtD
Mexiletine—Paraesthesia—Methotrexate—testicular cancer	0.000331	0.000814	CcSEcCtD
Mexiletine—Discomfort—Doxorubicin—testicular cancer	0.000329	0.000809	CcSEcCtD
Mexiletine—Dyspnoea—Methotrexate—testicular cancer	0.000329	0.000809	CcSEcCtD
Mexiletine—Somnolence—Methotrexate—testicular cancer	0.000328	0.000806	CcSEcCtD
Mexiletine—Dry mouth—Doxorubicin—testicular cancer	0.000326	0.000801	CcSEcCtD
Mexiletine—Dyspepsia—Methotrexate—testicular cancer	0.000325	0.000798	CcSEcCtD
Mexiletine—Hypotension—Epirubicin—testicular cancer	0.000322	0.000793	CcSEcCtD
Mexiletine—Confusional state—Doxorubicin—testicular cancer	0.000322	0.000792	CcSEcCtD
Mexiletine—Oedema—Doxorubicin—testicular cancer	0.000319	0.000785	CcSEcCtD
Mexiletine—Fatigue—Methotrexate—testicular cancer	0.000318	0.000782	CcSEcCtD
Mexiletine—Pain—Methotrexate—testicular cancer	0.000315	0.000776	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000314	0.000773	CcSEcCtD
Mexiletine—Shock—Doxorubicin—testicular cancer	0.000314	0.000773	CcSEcCtD
Mexiletine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000313	0.000769	CcSEcCtD
Mexiletine—Paraesthesia—Epirubicin—testicular cancer	0.00031	0.000762	CcSEcCtD
Mexiletine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000309	0.000759	CcSEcCtD
Mexiletine—Dyspnoea—Epirubicin—testicular cancer	0.000308	0.000757	CcSEcCtD
Mexiletine—Somnolence—Epirubicin—testicular cancer	0.000307	0.000754	CcSEcCtD
Mexiletine—Feeling abnormal—Methotrexate—testicular cancer	0.000304	0.000747	CcSEcCtD
Mexiletine—Dyspepsia—Epirubicin—testicular cancer	0.000304	0.000747	CcSEcCtD
Mexiletine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000302	0.000742	CcSEcCtD
Mexiletine—Hypotension—Doxorubicin—testicular cancer	0.000298	0.000734	CcSEcCtD
Mexiletine—Fatigue—Epirubicin—testicular cancer	0.000298	0.000732	CcSEcCtD
Mexiletine—Pain—Epirubicin—testicular cancer	0.000295	0.000726	CcSEcCtD
Mexiletine—Constipation—Epirubicin—testicular cancer	0.000295	0.000726	CcSEcCtD
Mexiletine—Abdominal pain—Methotrexate—testicular cancer	0.000291	0.000717	CcSEcCtD
Mexiletine—Body temperature increased—Methotrexate—testicular cancer	0.000291	0.000717	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000291	0.000715	CcSEcCtD
Mexiletine—Paraesthesia—Doxorubicin—testicular cancer	0.000287	0.000705	CcSEcCtD
Mexiletine—Dyspnoea—Doxorubicin—testicular cancer	0.000285	0.0007	CcSEcCtD
Mexiletine—Feeling abnormal—Epirubicin—testicular cancer	0.000284	0.000699	CcSEcCtD
Mexiletine—Somnolence—Doxorubicin—testicular cancer	0.000284	0.000698	CcSEcCtD
Mexiletine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000282	0.000694	CcSEcCtD
Mexiletine—Dyspepsia—Doxorubicin—testicular cancer	0.000281	0.000691	CcSEcCtD
Mexiletine—Fatigue—Doxorubicin—testicular cancer	0.000275	0.000677	CcSEcCtD
Mexiletine—Constipation—Doxorubicin—testicular cancer	0.000273	0.000672	CcSEcCtD
Mexiletine—Pain—Doxorubicin—testicular cancer	0.000273	0.000672	CcSEcCtD
Mexiletine—Abdominal pain—Epirubicin—testicular cancer	0.000273	0.000671	CcSEcCtD
Mexiletine—Body temperature increased—Epirubicin—testicular cancer	0.000273	0.000671	CcSEcCtD
Mexiletine—Hypersensitivity—Methotrexate—testicular cancer	0.000272	0.000668	CcSEcCtD
Mexiletine—Asthenia—Methotrexate—testicular cancer	0.000265	0.000651	CcSEcCtD
Mexiletine—Feeling abnormal—Doxorubicin—testicular cancer	0.000263	0.000647	CcSEcCtD
Mexiletine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000261	0.000642	CcSEcCtD
Mexiletine—Hypersensitivity—Epirubicin—testicular cancer	0.000254	0.000625	CcSEcCtD
Mexiletine—Abdominal pain—Doxorubicin—testicular cancer	0.000252	0.000621	CcSEcCtD
Mexiletine—Body temperature increased—Doxorubicin—testicular cancer	0.000252	0.000621	CcSEcCtD
Mexiletine—Diarrhoea—Methotrexate—testicular cancer	0.000252	0.00062	CcSEcCtD
Mexiletine—Asthenia—Epirubicin—testicular cancer	0.000248	0.000609	CcSEcCtD
Mexiletine—Dizziness—Methotrexate—testicular cancer	0.000244	0.0006	CcSEcCtD
Mexiletine—Diarrhoea—Epirubicin—testicular cancer	0.000236	0.000581	CcSEcCtD
Mexiletine—Hypersensitivity—Doxorubicin—testicular cancer	0.000235	0.000579	CcSEcCtD
Mexiletine—Vomiting—Methotrexate—testicular cancer	0.000234	0.000577	CcSEcCtD
Mexiletine—Rash—Methotrexate—testicular cancer	0.000232	0.000572	CcSEcCtD
Mexiletine—Dermatitis—Methotrexate—testicular cancer	0.000232	0.000571	CcSEcCtD
Mexiletine—Headache—Methotrexate—testicular cancer	0.000231	0.000568	CcSEcCtD
Mexiletine—Asthenia—Doxorubicin—testicular cancer	0.000229	0.000563	CcSEcCtD
Mexiletine—Dizziness—Epirubicin—testicular cancer	0.000228	0.000561	CcSEcCtD
Mexiletine—Vomiting—Epirubicin—testicular cancer	0.000219	0.00054	CcSEcCtD
Mexiletine—Nausea—Methotrexate—testicular cancer	0.000219	0.000539	CcSEcCtD
Mexiletine—Diarrhoea—Doxorubicin—testicular cancer	0.000218	0.000537	CcSEcCtD
Mexiletine—Rash—Epirubicin—testicular cancer	0.000218	0.000535	CcSEcCtD
Mexiletine—Dermatitis—Epirubicin—testicular cancer	0.000217	0.000535	CcSEcCtD
Mexiletine—Headache—Epirubicin—testicular cancer	0.000216	0.000532	CcSEcCtD
Mexiletine—Dizziness—Doxorubicin—testicular cancer	0.000211	0.000519	CcSEcCtD
Mexiletine—Nausea—Epirubicin—testicular cancer	0.000205	0.000504	CcSEcCtD
Mexiletine—Vomiting—Doxorubicin—testicular cancer	0.000203	0.000499	CcSEcCtD
Mexiletine—Rash—Doxorubicin—testicular cancer	0.000201	0.000495	CcSEcCtD
Mexiletine—Dermatitis—Doxorubicin—testicular cancer	0.000201	0.000495	CcSEcCtD
Mexiletine—Headache—Doxorubicin—testicular cancer	0.0002	0.000492	CcSEcCtD
Mexiletine—Nausea—Doxorubicin—testicular cancer	0.00019	0.000466	CcSEcCtD
